Polling Station

Poll 02/01/2019 – 31/01/2019

The common femoral artery (CFA) disease

Gender: Male

Age: 73 years old

Comorbidity: Arterial hypertension, hypercholesterinemia, coronary artery disease, previous CABG

Symptoms:  Claudication, Rutherford stage 3

Previous operations: None

ABI: 0.5

Question #1

Which is your primary treatment for de novo common femoral artery disease?
  • Surgery
  • Endovascular treatment
Question #2

Which is the combined morbidity/mortality rate following surgical treatment of common femoral artery disease:
  • <5%
  • 5-15%
  • 16-30%
  • 31-50%
  • >50%
Question #3

Which of the following characteristics might be an indication for endovascular CFA treatment?
  • Severe obesity
  • Chronic steroid use
  • Prior groin surgery
  • Increased comorbidity
  • None of them, endovascular treatment is not an option
Question #4

Which of the following modalities would be your primary endovascular CFA treatment option:
  • Plain angioplasty
  • Drug-coated balloon angioplasty (DCB)
  • Vessel preparation and DCB angioplasty
  • Bare metal stent
  • Drug-eluting stent
  • Stent-graft
Question #5

Which of the following characteristics might be a contraindication for the endovascular CFA treatment?
  • Concomitant deep femoral artery disease
  • Concomitant SFA disease
  • Severe calcification
  • Young age
  • There is no contraindication for endovascular treatment
Question #6

In case of rest pain (Rutherford 4) and coexisitng CFA and SFA disease, do you think that CFA revascularization only is sufficient?
  • Yes
  • No, I would go also for SFA revascularization/bypass
Question #7

In case of minor tissue loss (Rutherford 5) and coexisitng CFA and SFA disease, do you think that CFA revascularization only is sufficient?
  • Yes
  • No, I would go also for SFA revascularization/bypass